Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.
Tkáč, I
Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes. [electronic resource] - Diabetes, obesity & metabolism Feb 2013 - 189-91 p. digital
Publication Type: Journal Article
1463-1326
10.1111/j.1463-1326.2012.01691.x doi
Alleles
Diabetes Mellitus, Type 2--drug therapy
Dose-Response Relationship, Drug
Double-Blind Method
Female
Genotype
Humans
Hypoglycemic Agents--pharmacology
Male
Metformin--pharmacology
Middle Aged
Organic Cation Transport Proteins
Polymorphism, Single Nucleotide
Treatment Outcome
Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes. [electronic resource] - Diabetes, obesity & metabolism Feb 2013 - 189-91 p. digital
Publication Type: Journal Article
1463-1326
10.1111/j.1463-1326.2012.01691.x doi
Alleles
Diabetes Mellitus, Type 2--drug therapy
Dose-Response Relationship, Drug
Double-Blind Method
Female
Genotype
Humans
Hypoglycemic Agents--pharmacology
Male
Metformin--pharmacology
Middle Aged
Organic Cation Transport Proteins
Polymorphism, Single Nucleotide
Treatment Outcome